Newsroom

Sorted by: Latest

-

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-MED3 (SEMT 2026-MED3)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 16 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-MED3 (SEMT 2026-MED3), a $554.6 million prime RMBS transaction backed by 583 loans originated under Physician or Doctor Loan underwriting programs. These loans, generally referred to by KBRA as Medical Professional Mortgages (MPM), are typically originated through specialized prime mortgage programs designed for healthcare professionals with high earni...
-

Alnylam Announces $1 Billion Share Repurchase Program and Change in Commercial Leadership

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that its Board of Directors has authorized a $1 billion share repurchase program and that the Company will transition to new commercial leadership as it enters its next phase of growth. "Today we announced two important decisions, both of which demonstrate our conviction in Alnylam's future," said Amy Schulman, Chair of Alnylam's Board of Directors. "Alnylam ha...
-

KBRA Assigns Rating to MidCap Financial Issuer Trust's $500 Million Senior Unsecured Notes due November 2029

NEW YORK--(BUSINESS WIRE)--KBRA assigns a rating of A- to MidCap Financial Issuer Trust's $500 million 7.050% senior unsecured notes due November 15, 2029. The rating Outlook is Stable. MidCap Financial Issuer Trust is a wholly-owned subsidiary of MidCap FinCo Intermediate LLC ("the company" or "MidCap"), which serves as guarantor of the debt. The proceeds will be used to repay senior secured debt. Headquartered in Bethesda, MD, the company is a limited liability company that has operated since...
-

Evommune Announces $30 Million Private Placement

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--Evommune, Inc. (“Evommune” or the “Company”) (NYSE: EVMN), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that it has entered into a securities purchase agreement to sell 4,966,889 shares of its common stock to a select group of dedicated healthcare institutional investors in a private placement. The purchase price of each share of common stock is $6.0...
-

Granite REIT Announces Three-for-One Unit Split

TORONTO--(BUSINESS WIRE)--Granite Real Estate Investment Trust (TSX: GRT.UN) (“Granite” or the “Trust”) announced today that, pursuant to the terms of Granite’s Declaration of Trust, which permits a subdivision of Granite’s units by Granite’s trustees, its board of trustees approved a three-for-one split of the Trust’s outstanding units (the “Unit Split”) for unitholders of record at the close of business on November 18, 2026 (the “Record Date”). On November 23, 2026 (the “Payment Date”) unitho...
-

Finward Bancorp Announces Dividend

MUNSTER, Ind.--(BUSINESS WIRE)--Finward Bancorp (Nasdaq: FNWD) (the “Bancorp” or “Finward”), the holding company for Peoples Bank (the “Bank”), today announced that on November 4, 2026 the Board of Directors of Finward declared a dividend of $0.12 per share on Finward’s common stock payable on December 2, 2026 to shareholders of record at the close of business on November 18, 2026. About Finward Bancorp Finward Bancorp is a locally managed and independent financial holding company headquartered...
-

Mercado Libre Revenue Reaches $10.75 Billion in Q3 2026, up 45% Year Over Year

MONTEVIDEO, Uruguay--(BUSINESS WIRE)--Mercado Libre (NASDAQ: MELI), Latin America's leading e-commerce and fintech platform, today announced its financial results for the third quarter ended September 30, 2026. Net revenue and financial income grew 45% YoY, reaching $10.75 billion, with Brazil delivering the strongest growth. Income from operations reached $676 million, with a 6.3% margin that fell slightly QoQ. This reflects investments in fulfillment capacity, up almost 20% QoQ, the cost of m...
-

Cannae Holdings, Inc. Announces Quarterly Cash Dividend of $0.15

LAS VEGAS--(BUSINESS WIRE)--Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be payable December 31, 2026, to shareholders of record as of December 17, 2026. About Cannae Holdings, Inc. We primarily acquire interests in operating companies and are actively engaged in managing and operating a core group of those companies. We believe that our long-term ownership...
-

Pan American Silver Reports Third Quarter 2026 Financial Results

VANCOUVER, British Columbia--(BUSINESS WIRE)--Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American" or the "Company") reports third quarter ("Q3 2026") financial results. The Company will host a conference call and webcast on November 5, 2026 to discuss the results; details provided further in this news release. "Pan American continues to generate robust free cash flow. In the third quarter, we generated $377 million of Attributable(1) Free Cash Flow and returned $300 million to sh...
-

Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals

PALO ALTO, Calif. & NEW YORK & CHENGDU, China--(BUSINESS WIRE)--Evommune, Inc. (NYSE: EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing therapies for chronic inflammatory diseases, and Hinova Pharmaceuticals Inc. (SSE: 688302) today announced an exclusive license agreement granting Evommune worldwide rights outside of Greater China to develop, manufacture and commercialize EVO570 (formerly HC118 and known as HP570 in Greater China), an oral VAV1-directed mol...